Marked and independent prognostic significance of the CpG island methylator phenotype in neuroblastomas

Cancer Letters

Volumn 247, Issue 2, 2007, Pages 253-258

  Abe, Masanobu ^a   Westermann, Frank ^b   Nakagawara, Akira ^c   Takato, Tsuyoshi ^a   Schwab, Manfred ^b   Ushijima, Toshikazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CHIBA CANCER CENTER   (Japan)

Author keywords

CIMP; Methylation; MS RDA; N myc; Neuroblastoma

Indexed keywords

ARTICLE; CANCER SURVIVAL; CPG ISLAND; DISEASE FREE SURVIVAL; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; ONCOGENE C MYB; OVERALL SURVIVAL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CPG ISLANDS; DNA METHYLATION; HUMANS; INFANT; INFANT, NEWBORN; NEUROBLASTOMA; PHENOTYPE; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33846922849     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.05.001     Document Type: Article

References (17)

1. Schwab M., Westermann F., Hero B., and Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 4 (2003) 472-480
2. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3 (2003) 203-216
3. Schwab M., Alitalo K., Klempnauer K.H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G., Goldstein M., and Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305 (1983) 245-248
4. Seeger R.C., Brodeur G.M., Sather H., Dalton A., Siegel S.E., Wong K.Y., and Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med. 313 (1985) 1111-1116
5. Kaneko Y., Kanda N., Maseki N., Sakurai M., Tsuchida Y., Takeda T., and Okabe I. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 47 (1987) 311-318
6. Nakagawara A., Arima-Nakagawara M., Scavarda N.J., Azar C.G., Cantor A.B., and Brodeur G.M. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N. Engl. J. Med. 328 (1993) 847-854
7. Ushijima T., Morimura K., Hosoya Y., Okonogi H., Tatematsu M., Sugimura T., and Nagao M. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. Proc. Natl. Acad. Sci. USA 94 (1997) 2284-2289
8. Kaneda A., Takai D., Kaminishi M., Okochi E., and Ushijima T. Methylation-sensitive representational difference analysis and its application to cancer research. Ann. NY Acad. Sci. 983 (2003) 131-141
9. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer 5 (2005) 223-231
10. Abe M., Ohira M., Kaneda A., Yagi Y., Yamamoto S., Kitano Y., Takato T., Nakagawara A., and Ushijima T. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Res. 65 (2005) 828-834
11. Toyota M., Ahuja N., Ohe-Toyota M., Herman J.G., Baylin S.B., and Issa J.P. CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96 (1999) 8681-8686
12. Tilstone C. DNA microarrays: vital statistics. Nature 424 (2003) 610-612
13. London W.B., Boni L., Simon T., Berthold F., Twist C., Schmidt M.L., Castleberry R.P., Matthay K.K., Cohn S.L., and De Bernardi B. The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives. Cancer Lett. 228 (2005) 257-266
14. Kaneda A., Kaminishi M., Sugimura T., and Ushijima T. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett. 212 (2004) 203-210
15. Alaminos M., Davalos V., Cheung N.K., Gerald W.L., and Esteller M. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J. Natl. Cancer Inst. 96 (2004) 1208-1219
16. Alaminos M., Davalos V., Ropero S., Setien F., Paz M.F., Herranz M., Fraga M.F., Mora J., Cheung N.K., Gerald W.L., and Esteller M. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res. 65 (2005) 2565-2571
17. Misawa A., Inoue J., Sugino Y., Hosoi H., Sugimoto T., Hosoda F., Ohki M., Imoto I., and Inazawa J. Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res. 65 (2005) 10233-10242